WASHINGTON (Reuters) - The U.S. Food and Drug Administration authorized Pfizer Inc (NYSE:PFE)'s COVID-19 vaccine for emergency use on Friday, the New York Times reported, citing two people with knowledge of the decision who spoke on condition of anonymity.